New Ultrasonic Process
2.8 million euros for eZono AG in Jena
eZono AG in Jena has received 2.8 million euros of new capital for further development as well as preparation for market launch of the first generation product. In addition to bm|t beteiliungsmanagement thüringen gmbh and KfW, both domestic and international private investors have taken shares in the Jena-based medical technology group.
eZono develops totally new applications and systems for medical ultrasonic diagnostics. The equipment is easier to use than existing systems and can be operated by non-specialists, too. This opens up new potential with regard to cost efficiency in ultrasonic diagnostics. In contrast to hitherto existing equipment, the eZono systems offer a broad range of applications within the size and weight of a notebook and can therefore be used practically anywhere.
Ultrasonic devices can help, e.g. in the evaluation of potential strokes. However, this test is currently only carried out on approximately 2% of the population over the age of 50, due to the complexity and cost. In future, by carrying out an eZono ultrasonic scan of the carotid artery, the GP will be better able to assess the patient’s likelihood of suffering a stroke and thereby considerably reduce the risk by implementing preventative measures.
The first-generation product is expected to be available on the European market next year.
eZono AG was founded in 2004 and presently employs a staff of 20.
Contact
eZono AG
Allan Dunbar / André Jäkel
D‑07745 Jena
+49 (0) 3641 579–780
+49 (0) 3641 579–781
www.ezono.com